Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines - monoclonal microbials. Monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. These new medicines are broadly applicable across many diseases - including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. Monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. By finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, Evelo can improve the speed, cost and success of drug discovery and development. Evelo's platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. Evelo Biosciences was conceived and created within VentureLabs , Flagship Pioneering's institutional innovation foundry, and launched by Flagship in 2015.Evelo Biosciences is a small health care company based in Cambridge, MA with only 75 employees and an annual revenue of $11.0M.
In demand companies are hiring!
Let us apply for you!
-
Evelo Biosciences employee reviews
Be the first to review!
Do you work at Evelo Biosciences?
Help job seekers learn about working at Evelo Biosciences
Zippia gives an in-depth look into the details of Evelo Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Evelo Biosciences. The employee data is based on information from people who have self-reported their past or current employments at Evelo Biosciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Evelo Biosciences. The data presented on this page does not represent the view of Evelo Biosciences and its employees or that of Zippia.
Evelo Biosciences may also be known as or be related to EVELO BIOSCIENCES, INC., Evelo Biosciences, Evelo Biosciences Inc, Evelo Biosciences, Inc. and Evelo Therapeutics, Inc.